Arthur Caplan

Daniel Ives, co-founder of Shift Bioscience, discusses groundbreaking gene therapies aimed at reversing aging and explores how reprogramming can reset cellular age. Liz Parrish, founder of BioViva, shares her experience with unapproved gene therapies and advocates for faster access for terminal patients. Medical ethicist Arthur Caplan raises concerns about the moral implications of life extension, warning that longevity treatments could exacerbate inequality. They dive into the risks, motivations, and future potential of regenerative medicine.

Exploring the dark history of lobotomies, from their origins to ethical considerations. Discussing the misuse of lobotomies on minorities and veterans post-WWII. Delving into historical and contemporary perspectives on brain surgeries, including deep brain stimulation. Highlighting ethical considerations in neurosurgery and advancements in brain stimulation devices, as well as the importance of ethics in rapidly developing fields like AI and neurology.

Join bioethicist Arthur Caplan of NYU as he tackles medicine's toughest ethical dilemmas. He critiques biomedical profit motives, arguing for community-focused ethics over individualism in pandemics. Caplan reflects on his changing views regarding assisted dying and face transplants, emphasizing the need for public engagement in bioethics. The hosts also touch on malaria's global impact and the need for better funding and prevention strategies. It's a riveting discussion on how ethics can shape healthcare for the better.